HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding the U.S. Food and Drug Administration (FDA) for releasing new data to help generic drug competitors:
Click here for the full statement.
Related Posts
HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
June 19, 2019
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA)...
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA CEO to Lead Panel Discussion on Innovation at AdvaMed’s MedTech Conference
September 23, 2019
Washington, DC (September 23, 2019) – The Healthcare Supply Chain...